Cwm Lowered Its Dexcom (DXCM) Stake; Shorts at YINGLI GREEN ENERGY HOLDING COMPANY LIMI (YGEHY) Lowered By 0.47%

DexCom, Inc. (NASDAQ:DXCM) Logo

Cwm Llc decreased Dexcom Inc (DXCM) stake by 26.28% reported in 2018Q3 SEC filing. Cwm Llc sold 9,255 shares as Dexcom Inc (DXCM)’s stock declined 14.95%. The Cwm Llc holds 25,966 shares with $3.71M value, down from 35,221 last quarter. Dexcom Inc now has $12.91 billion valuation. The stock increased 2.99% or $4.16 during the last trading session, reaching $143.49. About 1.60 million shares traded or 22.74% up from the average. DexCom, Inc. (NASDAQ:DXCM) has risen 105.85% since March 2, 2018 and is uptrending. It has outperformed by 105.85% the S&P500. Some Historical DXCM News: 27/03/2018 – FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes; 27/03/2018 – $DXCM FDA approves the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes; 08/03/2018 – CORRECTED-WAVEFORM TECHNOLOGIES (NOT DEXCOM INC) – PTAB RULED 2 EARLY PATENTS HELD BY WAVEFORM ARE NOT INVALID, BASED ON CHALLENGES BROUGHT BY DEXCOM; 27/03/2018 – Dexcom Glucose Monitoring System, Dexcom G6, Gets FDA Approval; 02/05/2018 – DEXCOM SEES 2018 REV. $850M-$860M, SAW $830M-$850M; 08/03/2018 WaveForm Technologies Receives Favorable Decision on Critical Glucose Monitoring Patents; 28/03/2018 – DEXCOM INC DXCM.O : COWEN AND COMPANY RAISES TARGET PRICE TO $75 FROM $70; 21/03/2018 – ClinicalTrial US: Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test; 08/03/2018 – WAVEFORM: PTAB UPHOLDS PATENTS CHALLENGED BY DEXCOM; 22/05/2018 – DEXCOM Short Thesis

YINGLI GREEN ENERGY HOLDING COMPANY LIMI (OTCMKTS:YGEHY) had a decrease of 0.47% in short interest. YGEHY’s SI was 233,000 shares in March as released by FINRA. Its down 0.47% from 234,100 shares previously. With 48,400 avg volume, 5 days are for YINGLI GREEN ENERGY HOLDING COMPANY LIMI (OTCMKTS:YGEHY)’s short sellers to cover YGEHY’s short positions. The stock increased 33.33% or $0.05 during the last trading session, reaching $0.2. About 46,627 shares traded or 88.93% up from the average. Yingli Green Energy Holding Company Limited (OTCMKTS:YGEHY) has 0.00% since March 2, 2018 and is . It has by 0.00% the S&P500.

Yingli Green Energy Holding Company Limited, together with its subsidiaries, designs, develops, makes, assembles, sells, and installs photovoltaic products. The company has market cap of $3.64 million. The firm offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects. It currently has negative earnings. It is also involved in the research, manufacture, sale, and installation of renewable energy products; marketing and sale of PV products and related accessories; and import and export trading activities, as well as invests in renewable energy projects.

Cwm Llc increased Oracle Corp (NYSE:ORCL) stake by 72,524 shares to 311,465 valued at $16.06M in 2018Q3. It also upped 3M Co (NYSE:MMM) stake by 3,394 shares and now owns 4,144 shares. Sysco Corp (NYSE:SYY) was raised too.

More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: which released: “DexCom’s (DXCM) Q4 Earnings Beat, International Revenues Up – Nasdaq” on February 25, 2019, also with their article: “DexCom (DXCM) to Report Q4 Earnings: What’s in the Cards? – Nasdaq” published on February 13, 2019, published: “DexCom Q4 revenue up 53% – Seeking Alpha” on February 21, 2019. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: and their article: “DexCom Q4 2018 Earnings Preview – Seeking Alpha” published on February 20, 2019 as well as‘s news article titled: “DexCom (DXCM) Q4 Earnings and Revenues Top Estimates – Nasdaq” with publication date: February 21, 2019.

Among 8 analysts covering DexCom (NASDAQ:DXCM), 4 have Buy rating, 0 Sell and 4 Hold. Therefore 50% are positive. DexCom had 13 analyst reports since September 12, 2018 according to SRatingsIntel. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Equal-Weight” rating by Morgan Stanley on Thursday, October 11. Northland Capital upgraded the shares of DXCM in report on Wednesday, September 12 to “Market Perform” rating. The firm has “Buy” rating by Oppenheimer given on Friday, February 22. The company was maintained on Tuesday, January 8 by UBS. The firm has “Buy” rating given on Friday, February 22 by Piper Jaffray. Morgan Stanley maintained the shares of DXCM in report on Monday, February 25 with “Equal-Weight” rating. The firm has “Hold” rating given on Wednesday, February 20 by Northland Capital. On Friday, February 22 the stock rating was maintained by Cowen & Co with “Buy”. The firm earned “Outperform” rating on Tuesday, October 23 by Raymond James. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Neutral” rating by Goldman Sachs on Friday, October 19.

DexCom, Inc. (NASDAQ:DXCM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.